Viral load-guided immunosuppression after lung transplantation (VIGILung) —study protocol for a randomized controlled trial
DiscussionThe results of this randomized controlled trial may reduce the toxicity of immunosuppression after lung transplantation while maintaining the efficacy of immunosuppression. Study results are transferable to all other solid organ transplantations.Trial registrationClinicalTrials.govNCT04198506. Registered on 12 December 2019
Source: Trials - Category: Research Source Type: clinical trials
More News: Bone Graft | Lung Transplant | Prograf | Research | Study | Tacrolimus | Toxicology | Transplant Surgery | Transplants